MedPath

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain

Phase 3
Completed
Conditions
Ankle Sprain
Interventions
Registration Number
NCT01255423
Lead Sponsor
Novartis
Brief Summary

The purpose of this study is to evaluate the efficacy of Diclofenac Sodium Topical (DSG) 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
206
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diclofenac sodium topical gel 1%Diclofenac sodium topical gel 1%-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Pain on Movement72 hours

Pain on movement at 72 hours assessed on a 100 mm visual analog scale with anchors at 0= "No pain" and 100= "Extreme pain"

Secondary Outcome Measures
NameTimeMethod
Pain on Movement24 hours and 7 days

Pain on movement at 24 hours and 7 days assessed on a 100 mm visual analog scale with anchors at 0= "No pain" and 100= "Extreme pain"

Onset of Pain ReliefDay 1

Onset of perceptible pain relief

TendernessChange from baseline at 24 and 72 hours, 7 days

Tenderness at 24 and 72 hours and 7 days. Change from baseline. Tenderness was measured by a calibrated algometer in order to quantify the pressure pain threshold, a measure of tenderness.

Ankle Joint Function24 and 72 hours, 7 days

Ankle joint function score (Karlsson Scoring scale which ranges from 0 "worst possible score" to 90 "best possible score")at 24 and 72 hours and 7 days.

© Copyright 2025. All Rights Reserved by MedPath